Literature DB >> 19752101

Cases: Reversible cerebellar syndrome caused by metronidazole.

Justyna R Sarna1, A Keith W Brownell, Sarah Furtado.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19752101      PMCID： PMC2764756          DOI： 10.1503/cmaj.090591

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  Reversible metronidazole-induced lesions of the cerebellar dentate nuclei.

Authors:  Bryan K Woodruff; Eelco F M Wijdicks; William F Marshall
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

2.  MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings.

Authors:  E Kim; D G Na; E Y Kim; J H Kim; K R Son; K H Chang
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

3.  Neurologic toxicity associated with high-dose metronidazole therapy.

Authors:  S Frytak; C H Moertel; D S Childs
Journal:  Ann Intern Med       Date:  1978-03       Impact factor: 25.391

4.  Central nervous system toxicity associated with metronidazole therapy.

Authors:  R K Kusumi; J F Plouffe; R H Wyatt; R J Fass
Journal:  Ann Intern Med       Date:  1980-07       Impact factor: 25.391

5.  Metronidazole: newly recognized cause of autonomic neuropathy.

Authors:  Lisa D Hobson-Webb; E Steve Roach; Peter D Donofrio
Journal:  J Child Neurol       Date:  2006-05       Impact factor: 1.987

6.  Evaluation of metronidazole toxicity: a prospective study.

Authors:  K Kapoor; M Chandra; D Nag; J K Paliwal; R C Gupta; R C Saxena
Journal:  Int J Clin Pharmacol Res       Date:  1999

7.  Reversible optic neuropathy due to metronidazole.

Authors:  Nicole M McGrath; Brian Kent-Smith; Dianne M Sharp
Journal:  Clin Exp Ophthalmol       Date:  2007-08       Impact factor: 4.207

8.  Metronidazole-induced encephalopathy and inferior olivary hypertrophy: lesion analysis with diffusion-weighted imaging and apparent diffusion coefficient maps.

Authors:  Jung Im Seok; Hanseung Yi; Young Min Song; Won Yong Lee
Journal:  Arch Neurol       Date:  2003-12

Review 9.  Cerebellar ataxia following prolonged use of metronidazole: case report and literature review.

Authors:  Kalpeshkumar Patel; Israel Green-Hopkins; Stanley Lu; Allan R Tunkel
Journal:  Int J Infect Dis       Date:  2008-06-03       Impact factor: 3.623

10.  [Metronidazole-induced reversible cerebellar lesions and peripheral neuropathy].

Authors:  S Toumi; M Hammouda; A Essid; L Medimagh; L Ben Slamia; C Laouani-Kechrid
Journal:  Med Mal Infect       Date:  2008-12-31       Impact factor: 2.152
  10 in total
  5 in total

1.  Metronidazole-induced encephalopathy: a systematic review.

Authors:  Caspar Godthaab Sørensen; William Kristian Karlsson; Faisal Mohammad Amin; Mette Lindelof
Journal:  J Neurol       Date:  2018-12-07       Impact factor: 4.849

Review 2.  Clinical and Neuroradiological Spectrum of Metronidazole Induced Encephalopathy: Our Experience and the Review of Literature.

Authors:  Ujjawal Roy; Ajay Panwar; Alak Pandit; Susanta Kumar Das; Bhushan Joshi
Journal:  J Clin Diagn Res       Date:  2016-06-01

3.  Metronidazole-associated Neurologic Events: A Nested Case-control Study.

Authors:  Nick Daneman; Yi Cheng; Tara Gomes; Jun Guan; Muhammad M Mamdani; Farah E Saxena; David N Juurlink
Journal:  Clin Infect Dis       Date:  2021-06-15       Impact factor: 9.079

4.  Metronidazole-induced neurotoxicity developed in liver cirrhosis.

Authors:  Takatsugu Yamamoto; Koichiro Abe; Hajime Anjiki; Taro Ishii; Yasushi Kuyama
Journal:  J Clin Med Res       Date:  2012-07-20

5.  Neuro-Ophthalmological Manifestations after Intramuscular Medroxyprogesterone: A Forme Fruste of Idiopathic Intracranial Hypertension?

Authors:  Mandreker Bahall; Antonio Jose Reyes; Kanterpersad Ramcharan; Nadeem Hosein; Karan Seegobin; Krishni Bahall; Hiranyadeva Sharma; Stephanie Dhansingh; Amanda Mahabir
Journal:  Neurol Int       Date:  2016-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.